Triple
T19104424
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | BfArM |
E467617
|
entity |
| Predicate | officialName |
P66
|
FINISHED |
| Object | Bundesinstitut für Arzneimittel und Medizinprodukte |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Bundesinstitut für Arzneimittel und Medizinprodukte | Statement: [BfArM, officialName, Bundesinstitut für Arzneimittel und Medizinprodukte]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Bundesinstitut für Arzneimittel und Medizinprodukte Context triple: [BfArM, officialName, Bundesinstitut für Arzneimittel und Medizinprodukte]
-
A.
Federal Institute for Drugs and Medical Devices
chosen
The Federal Institute for Drugs and Medical Devices is Germany’s central regulatory authority responsible for the authorization, safety monitoring, and risk assessment of pharmaceuticals and medical devices.
-
B.
Paul Ehrlich Institute
The Paul Ehrlich Institute is Germany’s federal agency and research institution responsible for the evaluation, authorization, and monitoring of vaccines and biomedicines.
-
C.
Swissmedic
Swissmedic is the Swiss agency responsible for the authorization and supervision of therapeutic products, including medicines and medical devices, in Switzerland.
-
D.
European Union Drugs Agency
The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
-
E.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8dd05ac4c8190b1967d8f97f3fb2f |
completed | April 10, 2026, 11:20 a.m. |
| NER | Named-entity recognition | batch_69e5e3704c688190b84ef82da45d0862 |
completed | April 20, 2026, 8:27 a.m. |
Created at: April 10, 2026, 12:04 p.m.